- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 413/08 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing alicyclic rings
Patent holdings for IPC class C07D 413/08
Total number of patents in this class: 190
10-year publication summary
|
9
|
12
|
37
|
14
|
15
|
7
|
13
|
17
|
6
|
6
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| VALO Health, Inc. | 192 |
32 |
| Bristol-myers Squibb Company | 4721 |
8 |
| Cytokinetics, Inc. | 257 |
7 |
| Janssen Pharmaceutica N.V. | 3177 |
6 |
| Takeda Pharmaceutical Company Limited | 2714 |
5 |
| Assembly Biosciences, Inc. | 101 |
5 |
| Boehringer Ingelheim International GmbH | 4501 |
4 |
| Epizyme, Inc. | 359 |
4 |
| Merck Sharp & Dohme LLC | 3728 |
4 |
| Isosterix, Inc. | 8 |
4 |
| Genentech, Inc. | 4101 |
3 |
| Katholieke Universiteit Leuven | 1274 |
3 |
| Convelo Therapeutics, Inc. | 19 |
3 |
| Actio Biosciences, Inc. | 14 |
3 |
| Novartis AG | 10300 |
2 |
| F. Hoffmann-La Roche AG | 7832 |
2 |
| Merck Patent GmbH | 5725 |
2 |
| Amgen Inc. | 4425 |
2 |
| Sumitomo Chemical Company, Limited | 9016 |
2 |
| Board of Regents, The University of Texas System | 6079 |
2 |
| Other owners | 87 |